42
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus

, , , , , , , & show all
Pages 417-423 | Published online: 24 Dec 2022

References

  • [ADA] American Diabetes Association, The National Heart, Lung, and Blood Institute, the juvenile diabetes foundation international, et al.Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the american diabetes association; The national heart, lung, and blood institute; The juvenile diabetes foundation international; The national institute of diabetes and digestive and kidney diseases; and The american heart associationCirculation19991001132310477541
  • BoothGLKapralMKFungKRelation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort studyLancet2006368293616815377
  • DaneshJWheelerJGHirschfieldGMC-reactive protein and other circulating markers of inflammation in the prediction of coronary heart diseaseN Engl J Med200435013879715070788
  • DawsonAJeyaseelanSMorrisADB-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitusAm J Cardiol200596933416188519
  • de LemosJAMorrowDABentleyJHThe prognostic value of B-type natriuretic peptide in patients with acute coronary syndromesN Engl J Med200134510142111586953
  • DevereuxRBAlonsoDRLutasEMEchocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findingsAm J Cardiol19865745082936235
  • EpshteynVMorrisonKKrishnaswamyPUtility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetesDiabetes Care2003262081712832317
  • FangZYSchull-MeadeRLeanoRScreening for heart disease in diabetic subjectsAm Heart J20051493495415846276
  • GarciaMJMcNamaraPMGordonTMorbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up studyDiabetes197423105114359625
  • HowardBVBestLGGallowayJMCoronary heart disease risk equivalence in diabetes depends on concomitant risk factorsDiabetes Care200629391716443893
  • IshikawaCTsutamotoTFujiiMPrediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathyCirc J2006708576316799238
  • Janand-DelenneBSavinBHabibGSilent myocardial ischemia in patients with diabetes: who to screenDiabetes Care1999221396140010480499
  • MaedaKTsutamotoTWadaAPlasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunctionAm Heart J1998135825329588412
  • MargolisJRGillumRFFeinleibMCommunity surveillance for coronary heart disease: the Framingham Cardiovascular Disease Survey. Methods and preliminary resultsAm J Epidemiol1974100425364447106
  • MillerVMRedfieldMMMcConnellJPUse of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus riskCurr Vasc Pharmacol20075152517266610
  • MurciaAMHennekensCHLamasGAImpact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunctionArch Intern Med20041642273915534166
  • NdrepepaGKastratiABraunSN-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart diseaseAm J Med2006119e1816564781
  • NicholsGAGullionCMKoroCEThe incidence of congestive heart failure in type 2 diabetes: an updateDiabetes Care20042718798415277411
  • OgawaKOidaASugimuraHClinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: comparison of electrocardiography, chest radiography and echocardiographyCirc J200266122611999635
  • OgawaSTakeuchiKItoSPlasma BNP levels in the treatment of type 2 diabetes with pioglitazoneJ Clin Endocrinol Metab20038833936
  • PoirierPBogatyPGarneauCDiastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathyDiabetes Care20012451011194240
  • RidkerPMCannonCPMorrowDC-reactive protein levels and outcomes after statin therapyN Engl J Med200535220815635109
  • RidkerPMHennekensCHBuringJEC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenN Engl J Med20003428364310733371
  • SchulzeMBRimmEBLiTC-reactive protein and incident cardiovascular events among men with diabetesDiabetes Care2004278899415047644
  • ShahSJMarcusGMGerberILHigh-sensitivity C-reactive protein and parameters of left ventricular dysfunctionJ Card Fail20061261516500582
  • SprafkaJMBurkeGLFolsomARTrends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart SurveyDiabetes Care199114537431914792
  • StruthersADMorrisADScreening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deathLancet20023591430211978359
  • TsutamotoTWadaAMaedaKAttenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunctionCirculation199796509169244219
  • UK Prospective Diabetes Study GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet1998352837539742976
  • WakugawaYKiyoharaYTanizakiYC-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama StudyStroke200637273216306468
  • WangTJLarsonMGLevyDPlasma natriuretic peptide levels and the risk of cardiovascular events and deathN Engl J Med20043506556314960742
  • WeiMGibbonsLWKampertJBLow cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetesAnn Intern Med20001326051110766678
  • WilcoxRBousserMGBetteridgeDJEffects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)Stroke2007388657317290029
  • YoshimuraTSuzukiEEgawaKLow blood flow estimates in lower-leg arteries predict cardiovascular events in Japanese patients with type 2 diabetes with normal ankle-brachial indexesDiabetes Care20062918849016873797
  • YoshimuraMYasueHOkumuraKDifferent secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failureCirculation19938746498425293
  • ZulianiGVolpatoSBlèAHigh interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti studyAtherosclerosis20071923849016787648